id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-E-4324-0007,FDA,FDA-2018-E-4324,"Letter from U. S. Patent and Trademark Office to Rosenberg, Klein & Lee",Other,Letter(s),2024-02-21T05:00:00Z,2024,2,2024-02-21T05:00:00Z,,2024-02-21T14:49:04Z,,0,0,09000064863d607b
FDA-2018-E-4324-0006,FDA,FDA-2018-E-4324,"Notice of Final Determination from U.S Patent and Trademark Office to Rosenberg, Klein & Lee",Other,Letter(s),2024-02-20T05:00:00Z,2024,2,2024-02-20T05:00:00Z,,2024-02-20T21:18:55Z,,0,0,09000064863d6096
FDA-2018-E-4324-0005,FDA,FDA-2018-E-4324,Letter from U. S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-02-20T05:00:00Z,2024,2,2024-02-20T05:00:00Z,,2024-02-20T17:59:04Z,,0,0,090000648638964e
FDA-2018-E-4324-0004,FDA,FDA-2018-E-4324,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2023-07-13T04:00:00Z,2023,7,2023-07-13T04:00:00Z,,2023-07-13T18:27:56Z,,0,0,0900006485ca2486
FDA-2018-E-4324-0003,FDA,FDA-2018-E-4324,Determination of Regulatory Review Period for Purposes of Patent Extension; ANGELMED GUARDIAN SYSTEM,Notice,Determinations,2022-11-07T05:00:00Z,2022,11,2022-11-07T05:00:00Z,2023-01-07T04:59:59Z,2022-11-07T13:39:11Z,2022-24216,0,0,0900006485492c7c
FDA-2018-E-4324-0002,FDA,FDA-2018-E-4324,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2022-09-08T04:00:00Z,2022,9,2022-09-08T04:00:00Z,,2022-09-08T16:11:42Z,,0,0,09000064852cdc71
FDA-2018-E-4324-0001,FDA,FDA-2018-E-4324,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2019-05-13T04:00:00Z,2019,5,2019-05-13T04:00:00Z,,2019-05-13T18:20:01Z,,0,0,0900006483c73342